CERO   $1.99  -1.00% Market Closed

CERo Therapeutics Holdings, Inc.
Total Cash 3.65M
totalCashPerShare 0.072
EBITDA
Total Debt 2.15M
quickRatio 0.425
currentRatio 0.484
Total Revenue
debtToEquity
Revenue/Share
ROA -0.45279
ROE
grossProfits
freeCashflow 14.46M
operatingCashflow -6.63M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 12.16M
forwardPE
floatShares 22.53M
sharesOutstanding 150.31M
sharesShort 441.45K
sharesShortPriorMonth 266.34K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.58%
heldPercentInstitutions 0.04%
Short Ratio help_outline 0.02%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -0.524
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -2.75M
trailingEps -1.19%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 18
lastUpdated Nov. 2, 2024, 7:09 a.m.